Showing 121 - 140 results of 33,082 for search '(( 5 ((non decrease) OR (mean decrease)) ) OR ( 50 ((mg decrease) OR (a decrease)) ))', query time: 0.79s Refine Results
  1. 121
  2. 122

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127

    CM-DWM-EC chart using 30% decrease in the mean for the E(KeV). by Shumaila Nisar (20114256)

    Published 2024
    “…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    Subjects:
  14. 134
  15. 135
  16. 136

    Decreased MBP levels in the brain in <i>Large</i><sup><i>myd/myd</i></sup> mice. by Shigefumi Morioka (8893511)

    Published 2020
    “…The results are presented as the mean of at least three experiments. <b>B,</b> Whole-brain lysates of P7 control and <i>Large</i><sup><i>myd/myd</i></sup> mice (<i>n</i> = 5) were obtained for MBP immunoblotting. …”
  17. 137
  18. 138
  19. 139
  20. 140